108 related articles for article (PubMed ID: 9132551)
1. [Lipid status in patients on a chronic hemodialysis program].
Tepsić V; Ristić V; Perunicić G; Rasić Z; Pljesa S; Bokan L; Ranković N
Med Pregl; 1997; 50(1-2):45-7. PubMed ID: 9132551
[TBL] [Abstract][Full Text] [Related]
2. [Hyperinsulinism in hyperlipoproteinemia in patients on a chronic hemodialysis program].
Rasić-Milutinović Z; Perunicić-Peković G; Bokan L; Pljesa S; Ristić V; Tepsić V
Med Pregl; 1997; 50(5-6):220-3. PubMed ID: 9297055
[TBL] [Abstract][Full Text] [Related]
3. Pattern of lipid profile in patients on maintenance hemodialysis.
Maheshwari N; Ansari MR; Darshana MS; Lal K; Ahmed K
Saudi J Kidney Dis Transpl; 2010 May; 21(3):565-70. PubMed ID: 20427895
[TBL] [Abstract][Full Text] [Related]
4. [Visceral protein status and hyperlipoproteinemia in patients on hemodialysis].
Perunicić-Peković G; Rasić-Milutinović Z; Bokan L; Pljesa S; Tepsić V; Ristić V
Med Pregl; 1997; 50(3-4):112-4. PubMed ID: 9229681
[TBL] [Abstract][Full Text] [Related]
5. [Lipid profile in maintenance haemodialysis].
Jamoussi K; Ayedi F; Abida N; Kamoun K; Féki H; Chaabouni MN; Hammouda F; Bahloul I; Bellaj A; Hachicha J; Ellouz F
Pathol Biol (Paris); 2005 May; 53(4):217-20. PubMed ID: 15850955
[TBL] [Abstract][Full Text] [Related]
6. [Assessment of malonyldialdehyde concentration as a product of lipid peroxidation and lipid metabolism in patients on chronic dialysis].
Miler M; Zamojska S; Fijałkowski P; Lobos M; Paradowski MT
Pol Merkur Lekarski; 2006 Jun; 20(120):664-7. PubMed ID: 17007263
[TBL] [Abstract][Full Text] [Related]
7. [Apolipoproteins as risk factors in patients on a regular hemodialysis program].
Bokan L; Perunicić-Peković G; Rasić-Milutinović Z; Pljesa S; Tepsić V; Ristić V
Med Pregl; 1997; 50(7-8):293-5. PubMed ID: 9441214
[TBL] [Abstract][Full Text] [Related]
8. Incidence of gallstones in chronic renal failure patients undergoing hemodialysis: experience of a center in Turkey.
Altiparmak MR; Pamuk ON; Pamuk GE; Celik AF; Apaydin S; Cebi D; Mihmanli I; Erek E
Am J Gastroenterol; 2003 Apr; 98(4):813-20. PubMed ID: 12738461
[TBL] [Abstract][Full Text] [Related]
9. Does ingestion of regular coffee influence serum lipid profile in dialysis patients?
Grzegorzewska AE; Młot-Michalska M; Wobszal P
Adv Perit Dial; 2009; 25():181-6. PubMed ID: 19886342
[TBL] [Abstract][Full Text] [Related]
10. Association of serum lipid profile and arteriovenous fistula thrombosis in maintenance hemodialysis patients.
Kirkpantur A; Arici M; Altun B; Yilmaz MI; Cil B; Aki T; Bakkaloglu M; Turgan C
Blood Purif; 2008; 26(4):322-32. PubMed ID: 18487877
[TBL] [Abstract][Full Text] [Related]
11. Electronegative LDL and lipid abnormalities in patients undergoing hemodialysis and peritoneal dialysis.
Lobo J; Santos F; Grosso D; Lima R; Barreira AL; Leite M; Mafra D; Abdalla DS
Nephron Clin Pract; 2008; 108(4):c298-304. PubMed ID: 18434752
[TBL] [Abstract][Full Text] [Related]
12. Plasma concentrations of non-esterified fatty acids in chronic renal failure in the United Arab Emirates.
Gillett MP; Obineche EN; Khan ST; Abdulle AM
Saudi Med J; 2004 Nov; 25(11):1611-6. PubMed ID: 15573187
[TBL] [Abstract][Full Text] [Related]
13. [Dyslipidemia in patients being treated with peritoneal dialysis].
Zharfbin A
Vnitr Lek; 2006 Nov; 52(11):1051-7. PubMed ID: 17165524
[TBL] [Abstract][Full Text] [Related]
14. Associations between apolipoprotein E gene polymorphism and plasminogen activator inhibitor-1 and atherogenic lipid profile in dialysis patients.
Arikan H; Koc M; Sari H; Tuglular S; Ozener C; Akoglu E
Ren Fail; 2007; 29(6):713-9. PubMed ID: 17763167
[TBL] [Abstract][Full Text] [Related]
15. Chlamydia pneumoniae infection and ischemic heart disease in hemodialysis patients.
Wszola M; Kwiatkowski A; Nosek R; Podsiadly E; Meszaros J; Danielewicz R; Lisik W; Ostrowski K; Chmura A; Adadyński L; Paczek L; Durlik M; Tylewska-Wierzbanowska S; Rowiński W
Transplant Proc; 2006; 38(1):31-4. PubMed ID: 16504656
[TBL] [Abstract][Full Text] [Related]
16. [Hyperlipidemia in uremic patients in dialysis].
Docci D; Bilancioni R; Turci F; Baldrati L
Quad Sclavo Diagn; 1985 Dec; 21(4):424-9. PubMed ID: 3837917
[TBL] [Abstract][Full Text] [Related]
17. Effects of omega-3 fatty acid supplementation on lipid levels in endstage renal disease patients.
Bowden RG; Jitomir J; Wilson RL; Gentile M
J Ren Nutr; 2009 Jul; 19(4):259-66. PubMed ID: 19539180
[TBL] [Abstract][Full Text] [Related]
18. Effect of protein-restricted diet on serum lipids and atherosclerosis risk factors in patients with chronic renal failure.
Loschiavo C; Ferrari S; Panebianco R; Bedogna V; Oldrizzi L; Bonazzi L; Maschio G
Clin Nephrol; 1988 Mar; 29(3):113-8. PubMed ID: 3359702
[TBL] [Abstract][Full Text] [Related]
19. Lipoprotein alterations in hemodialysis: differences between diabetic and nondiabetic patients.
González AI; Schreier L; Elbert A; Berg G; Beresan H; López G; Wikinski R
Metabolism; 2003 Jan; 52(1):116-21. PubMed ID: 12524671
[TBL] [Abstract][Full Text] [Related]
20. Serum leptin, resistin, and lipid levels in patients with end stage renal failure with regard to dialysis modality.
Taskapan MC; Taskapan H; Sahin I; Keskin L; Atmaca H; Ozyalin F
Ren Fail; 2007; 29(2):147-54. PubMed ID: 17365928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
